ProShares Nanotechnology ETF
TINY
6 hedge funds and large institutions have $1.34M invested in ProShares Nanotechnology ETF in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 4 → 6 (+2)
3.84% more ownership
Funds ownership: 52.47% → 56.3% (+3.8%)
12% less capital invested
Capital invested by funds: $1.53M → $1.34M (-$191K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$178K |
| 2 |
SG Americas Securities
New York
|
+$139K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$32 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$149K |
| 2 |
Jane Street
New York
|
-$52.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$16.5K |
TINY Hedge Fund Activity: Q2 2022 in Review
6 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in ProShares Nanotechnology ETF (TINY) for Q2 2022, worth a combined $1.34M — down 12% from $1.53M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TINY positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Credit Suisse, opening a new position worth an estimated $178K. The largest seller was JP Morgan Chase, cutting an estimated $149K.
- 6 institutional investors held ProShares Nanotechnology ETF (TINY) as of Q2 2022, up from 4 in Q1 2022.
- Funds reported $1.34M of ProShares Nanotechnology ETF stock for Q2 2022, down 12% quarter-over-quarter.
- 2 funds opened new ProShares Nanotechnology ETF positions in Q2 2022 and 0 closed out, a net change of +2 holders.
- The largest ProShares Nanotechnology ETF buyer in Q2 2022 was Credit Suisse, an estimated $178K added.
- The largest ProShares Nanotechnology ETF seller in Q2 2022 was JP Morgan Chase, an estimated $149K sold.
Based on aggregated 13F filings for Q2 2022.